journal article·2017-07

Folic acid-decorated polyamidoamine dendrimer exhibits high tumor uptake and sustained highly localized retention in solid tumors: Its utility for local siRNA delivery

Leyuan Xu, W. Andrew Yeudall, Hu Yang

Acta Biomaterialia· Volume 57
Publisher page

Abstract

The utility of folic acid (FA)-decorated polyamidoamine dendrimer G4 (G4-FA) as a vector was investigated for local delivery of siRNA. In a xenograft HN12 (or HN12-YFP) tumor mouse model of head and neck squamous cell carcinomas (HNSCC), intratumorally (i.t.) injected G4-FA exhibited high tumor uptake and sustained highly localized retention in the tumors according to near infrared (NIR) imaging assessment. siRNA against vascular endothelial growth factor A (siVEGFA) was chosen as a therapeutic modality. Compared to the nontherapeutic treatment groups (PBS solution or dendrimer complexed with nontherapeutic siRNA against green fluorescent protein (siGFP)), G4-FA/siVEGFA showed tumor inhibition effects in single-dose and two-dose regimen studies. In particular, two doses of G4-FA/siVEGFA i.t. administered eight days apart resulted in a more profound inhibition of tumor growth, accompanied with significant reduction in angiogenesis, as judged by CD31 staining and microvessel counts. Tumor size reduction in the two-dose regimen study was ascertained semi-quantitatively by live fluorescence imaging of YFP tumors and independently supported antitumor effects of G4-FA/siVEGFA. Taken together, G4-FA shows high tumor uptake and sustained retention properties, making it a suitable platform for local delivery of siRNAs to treat cancers that are readily accessible such as HNSCC. Statement of significance Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide and is difficult to transfect for gene therapy. We developed folate receptor (FR)-targeted polyamidoamine (PAMAM) dendrimer for enhanced delivery of genes to HNSCC and gained in-depth understanding of how gene delivery and transfection in head and neck squamous cancer cells can be enhanced via FR-targeted PAMAM dendrimers. The results we report here are encouraging and present latest advances in using dendrimers for cancer therapies, in particular for HNSCC. Our work has demonstrated that localized delivery of FR-targeted PAMAM dendrimer G4 complexed with siVEGFA resulted in pronounced tumor suppression in an HN12 xenograft tumor model. Tumor suppression was attributed to enhanced tumor uptake of siRNA and prolonged nanoparticle retention in the tumor. Taken together, G4-FA shows high tumor uptake and sustained highly localized retention properties, making it a suitable platform for local delivery of siRNAs to treat cancers that are readily accessible such as HNSCC.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Dendrimers and Hyperbranched Polymers · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (54)

Show source-provided references
1. Risk genes in head and neck cancer: a systematic review and meta-analysis of last 5years10.1016/j.oraloncology.2013.12.007 ↗
2. Integration of molecular targeted therapy with radiation in head and neck cancer10.1016/j.pharmthera.2013.11.007 ↗
3. Health related quality of life in head and neck cancer treated with radiation therapy with or without chemotherapy: a systematic review10.1016/j.oraloncology.2014.01.015 ↗
4. Targeting tumour-supportive cellular machineries in anticancer drug development10.1038/nrd4201 ↗
5. Dendrimer-based RNA interference delivery for cancer therapy
6. Adenovirus-mediated transfer of tris-shRNAs induced apoptosis of nasopharyngeal carcinoma cell in vitro and in vivo10.1016/j.canlet.2011.05.028 ↗
7. Nuclear localization signal-enhanced RNA interference of EZH2 and Oct4 in the eradication of head and neck squamous cell carcinoma-derived cancer stem cells10.1016/j.biomaterials.2012.01.016 ↗
8. Systemic delivery of siRNA nanoparticles targeting RRM2 suppresses head and neck tumor growth10.1016/j.jconrel.2012.01.045 ↗
9. Is cancer gene therapy an empty suit?10.1016/S1470-2045(13)70173-6 ↗
10. Folic acid-decorated polyamidoamine dendrimer mediates selective uptake and high expression of genes in head and neck cancer cells10.2217/nnm-2016-0244 ↗
11. Engineered in-situ depot-forming hydrogels for intratumoral drug delivery10.1016/j.jconrel.2015.11.014 ↗
12. Chemoradiation therapy using cyclopamine-loaded liquid-lipid nanoparticles and lutetium-177-labeled core-crosslinked polymeric micelles10.1016/j.jconrel.2015.01.031 ↗
13. Delivery of antisense oligonucleotides using poly(alkylene oxide)-poly(propylacrylic acid) graft copolymers in conjunction with cationic liposomes10.1016/j.jconrel.2014.08.023 ↗
14. In vivo evaluation of matrix metalloproteinase responsive silk-elastinlike protein polymers for cancer gene therapy10.1016/j.jconrel.2015.06.022 ↗
15. An injectable acellular matrix scaffold with absorbable permeable nanoparticles improves the therapeutic effects of docetaxel on glioblastoma10.1016/j.biomaterials.2016.08.026 ↗
16. Pharmacokinetic and pharmacodynamic evaluation of a novel in situ forming poly(ethylene glycol)-based hydrogel for the controlled delivery of the camptothecins10.1016/j.jconrel.2006.03.002 ↗
17. Dendrimer-triglycine-EGF nanoparticles for tumor imaging and targeted nucleic acid and drug delivery10.1016/j.oraloncology.2010.07.001 ↗
18. Semi-Interpenetrating Network (sIPN) Co-Electrospun Gelatin/Insulin Fiber Formulation for Transbuccal Insulin Delivery10.1007/s11095-014-1461-9 ↗
19. Regulation of hepatocyte lipid metabolism and inflammatory response by 25-hydroxycholesterol and 25-hydroxycholesterol-3-sulfate10.1007/s11745-010-3451-y ↗
20. Co-delivery of cisplatin and rapamycin for enhanced anticancer therapy through synergistic effects and microenvironment modulation10.1021/nn5010815 ↗
21. Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes10.1038/nm.3833 ↗
22. IR-780 dye loaded tumor targeting theranostic nanoparticles for NIR imaging and photothermal therapy10.1016/j.biomaterials.2013.05.071 ↗
23. Cytosolic sulfotransferase 2B1b promotes hepatocyte proliferation gene expression in vivo and in vitro10.1152/ajpgi.00403.2011 ↗
24. Poly(glycoamidoamine)s: a broad class of carbohydrate-containing polycations for nucleic acid delivery10.1016/j.tibtech.2011.04.012 ↗
25. Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases10.1093/jb/mvs136 ↗
26. VEGF siRNA delivery system using arginine-grafted bioreducible poly(disulfide amine)10.1021/mp800161e ↗
27. Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNA effectively inhibits tumor growth in colon adenocarcinoma10.1016/j.ymthe.2006.03.022 ↗
28. In vivo silencing of a molecular target by short interfering RNA electroporation: tumor vascularization correlates to delivery efficiency10.1158/1535-7163.MCT-07-0319 ↗
29. Anti-angiogenic therapy increases intratumoral adenovirus distribution by inducing collagen degradation10.1038/gt.2012.42 ↗
30. Role for EPS8 in squamous carcinogenesis10.1093/carcin/bgn252 ↗
31. A folate receptor-targeting nanoparticle minimizes drug resistance in a human cancer model10.1021/nn200739q ↗
32. Injectable hydrogel-based drug delivery systems for local cancer therapy10.1016/j.drudis.2016.07.006 ↗
33. Application of near-infrared dyes for tumor imaging, photothermal, and photodynamic therapies10.1002/jps.23356 ↗
34. Cost-effectiveness of 5-aminolevulinic acid-induced fluorescence in malignant glioma surgery10.1016/j.nrl.2013.11.002 ↗
35. Multimodal imaging patterns predict survival in recurrent glioblastoma patients treated with bevacizumab10.1093/neuonc/now086 ↗
36. EGFR protein overexpression and gene amplification in squamous cell carcinomas of the esophagus10.1002/ijc.21454 ↗
37. In vivo optical imaging of integrin alphaV-beta3 in mice using multivalent or monovalent cRGD targeting vectors10.1186/1476-4598-6-41 ↗
38. Developing a peptide-based near-infrared molecular probe for protease sensing10.1021/bc049924s ↗
39. Near-infrared light triggered drug delivery system for higher efficacy of combined chemo-photothermal treatment
40. Photothermal and biodegradable polyaniline/porous silicon hybrid nanocomposites as drug carriers for combined chemo-photothermal therapy of cancer10.1016/j.actbio.2017.01.015 ↗
41. Real-time near-infrared bioimaging of a receptor-targeted cytotoxic dendritic theranostic agent10.1016/j.biomaterials.2016.11.011 ↗
42. Structural basis for molecular recognition of folic acid by folate receptors10.1038/nature12327 ↗
43. Liver-spleen axis: intersection between immunity, infections and metabolism10.3748/wjg.v19.i23.3534 ↗
44. Folate-mediated chemotherapy and diagnostics: an updated review and outlook10.1016/j.jconrel.2017.02.023 ↗
45. Polyethylene glycol (PEG)-dendron phospholipids as innovative constructs for the preparation of super stealth liposomes for anticancer therapy10.1016/j.jconrel.2014.12.008 ↗
46. Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery10.1007/s11095-007-9284-6 ↗
47. Nanodiamonds-mediated doxorubicin nuclear delivery to inhibit lung metastasis of breast cancer10.1016/j.biomaterials.2013.08.056 ↗
48. Bioactivity and circulation time of PEGylated NELL-1 in mice and the potential for osteoporosis therapy10.1016/j.biomaterials.2014.04.061 ↗
49. PEGylated polyamidoamine dendrimers with bis-aryl hydrazone linkages for enhanced gene delivery10.1021/bm100589g ↗
50. Arginine-terminated generation 4 PAMAM dendrimer as an effective nanovector for functional siRNA delivery in vitro and in vivo10.1021/bc4005156 ↗
51. Dihydromyricetin promotes autophagy and apoptosis through ROS-STAT3 signaling in head and neck squamous cell carcinoma10.18632/oncotarget.10836 ↗
52. Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck10.1158/0008-5472.CAN-05-0921 ↗
53. Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck10.1038/cgt.2008.35 ↗
54. POU2F1 activity regulates HOXD10 and HOXD11 promoting a proliferative and invasive phenotype in head and neck cancer10.18632/oncotarget.2492 ↗